Virginia Olivia Volpe, M.D.
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Virginia Volpe's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Virginia Volpe has written about over time.
Immunologic FactorsMelanomaProtein Kinase InhibitorsSEER ProgramLeukemia, Lymphocytic, Chronic, B-CellPhosphoproteinsMyelodysplastic SyndromesLeukemia, Myeloid, AcuteNeoplasms, Second PrimaryMutationLeukemia, Myelomonocytic, ChronicLeukemia, Myelomonocytic, JuvenileAnemiaNeutropeniaPrimary MyelofibrosisChromosome DeletionChromosomes, Human, Pair 6Ribosomal Proteins
To see the data from this visualization as text,
click here.
| Name | Number of Publications | First Publication Year | Most Recent Publication Year | Average Publication Date |
|---|
| Immunologic Factors | 1 | 2017 | 2017 | July 2017 |
| Melanoma | 1 | 2017 | 2017 | July 2017 |
| Protein Kinase Inhibitors | 1 | 2017 | 2017 | July 2017 |
| SEER Program | 1 | 2021 | 2021 | August 2021 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2019 | 2024 | December 2021 |
| Phosphoproteins | 2 | 2021 | 2022 | February 2022 |
| Myelodysplastic Syndromes | 5 | 2021 | 2023 | February 2022 |
| Leukemia, Myeloid, Acute | 2 | 2021 | 2022 | February 2022 |
| Neoplasms, Second Primary | 2 | 2021 | 2022 | February 2022 |
| Mutation | 6 | 2021 | 2024 | September 2022 |
| Leukemia, Myelomonocytic, Chronic | 1 | 2022 | 2022 | November 2022 |
| Leukemia, Myelomonocytic, Juvenile | 1 | 2022 | 2022 | November 2022 |
| Anemia | 1 | 2023 | 2023 | January 2023 |
| Neutropenia | 1 | 2023 | 2023 | January 2023 |
| Primary Myelofibrosis | 1 | 2024 | 2024 | March 2024 |
| Chromosome Deletion | 1 | 2024 | 2024 | June 2024 |
| Chromosomes, Human, Pair 6 | 1 | 2024 | 2024 | June 2024 |
| Ribosomal Proteins | 1 | 2024 | 2024 | June 2024 |